Key Insights

Highlights

Treatment Research

4 treatments under study, led by Emessages For Ssb

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04302480Not ApplicableUnknownPrimary

A Brief Intervention Programme on ASP

Showing all 1 trials

Research Network

Common Treatments

  • Emessages For Ssb1
  • Worksheets For Ssb1
  • Worksheets For Asp1
  • Emessages For Asp1

Active Sponsors

  • The University of Hong Kong1

Top Investigators

Activity Timeline